Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Luke A Selth
Affiliation
Adelaide Medical School, University of Adelaide
ORCID
Career Start Year
2002
Papers
87
H Index
36
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36743527
Targeting lipid metabolism in metastatic prostate cancer.
Ther Adv Med Oncol
2023
37673961
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer.
Br J Cancer
2023
37470668
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.
Cancer Discov
2023
37174737
Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington's Disease.
Cells
2023
37295428
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
Cancer Cell
2023
36859711
Length of positive surgical margins after radical prostatectomy: Does size matter? - A systematic review and meta-analysis.
Prostate Cancer Prostatic Dis
2023
36923279
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.
Cancer Res Commun
2022
35764869
Optical Cellular Micromotion: A New Paradigm to Measure Tumor Cells Invasion within Gels Mimicking the 3D Tumor Environments.
Small Methods
2022
33406413
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Cell Rep
2021
33547161
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
Cancer Res
2021
33834258
TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling.
Cell Mol Life Sci
2021
34737261
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Nat Commun
2021
34489572
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.
Nat Cell Biol
2021
34209750
Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer.
Cancers (Basel)
2021
34362796
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
Cancer Res
2021
34111999
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
SLAS Discov
2021
33973331
Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis.
BJU Int
2021
33462444
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Nat Med
2021
32209629
Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review.
BMJ Open
2020
31804971
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.
Endocr Relat Cancer
2020
32878981
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control.
Sci Transl Med
2020
30508726
Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.
Mol Immunol
2019
30237440
A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer.
Oncogene
2019
31556460
Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression.
EMBO J
2019
31200751
Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.
Genome Biol
2019
30728288
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.
Sci Transl Med
2019
31084623
VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.
Genome Biol
2019
30817318
Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Endocr Relat Cancer
2019
30391670
Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Mol Cell Endocrinol
2019
29258679
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.
Eur Urol
2018
30049486
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
Eur Urol
2018
29871889
miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking.
EMBO J
2018
29391407
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.
Sci Rep
2018
29497340
Data Mining of Small RNA-Seq Suggests an Association Between Prostate Cancer and Altered Abundance of 5' Transfer RNA Halves in Seminal Fluid and Prostatic Tissues.
Biomark Cancer
2018
29703916
A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.
Sci Rep
2018
29530945
New Opportunities for Targeting the Androgen Receptor in Prostate Cancer.
Cold Spring Harb Perspect Med
2018
27270433
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.
Oncogene
2017
28302679
Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer.
Cancer Res
2017
28430625
MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.
Oncotarget
2017
28473532
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.
Cancer Res
2017
28092670
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
Oncogene
2017
28978635
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.
Cancer Res
2017
28905400
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.
Prostate
2017
28011622
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
Cancer Res
2017
27634452
Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.
Mol Cell Endocrinol
2017
26940599
Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor.
BMC Cancer
2016
27799360
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence.
Endocr Relat Cancer
2016
27526951
A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Prostate
2016
27496708
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.
Cancer Res
2016
25597828
Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
Prostate
2015
1 - 50 of 87
Column Actions
Search
Recommended Authors
Wei Yuan
The Institute for Cancer Research
Career Start Year
2015
Number of shared co-authors
10
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Career Start Year
2014
Number of shared co-authors
13
Joshua Armenia
Oncology R&D
Career Start Year
2013
Number of shared co-authors
7
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year
2012
Number of shared co-authors
0
Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year
2012
Number of shared co-authors
10
Julie Livingstone
University of California los angeles
Career Start Year
2011
Number of shared co-authors
24
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year
2011
Number of shared co-authors
15
Sungyong You
Cedars-Sinai Medical Center
Career Start Year
2008
Number of shared co-authors
13
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Career Start Year
2008
Number of shared co-authors
13
Anne Haegert
University of British Columbia
Career Start Year
2008
Number of shared co-authors
18
John R Prensner
University of Michigan ann arbor
Career Start Year
2007
Number of shared co-authors
9
Changmeng Cai
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year
2006
Number of shared co-authors
10
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2005
Number of shared co-authors
1
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year
2005
Number of shared co-authors
24
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year
2003
Number of shared co-authors
13
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year
2001
Number of shared co-authors
22
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
4
Yuzhuo Wang
University of British Columbia
Career Start Year
2000
Number of shared co-authors
31
Nadia Boufaied
Research Institute of the McGill University Health Centre
Career Start Year
2000
Number of shared co-authors
11
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year
1999
Number of shared co-authors
16
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year
1999
Number of shared co-authors
17
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year
1999
Number of shared co-authors
0
Hayley C Whitaker
University College London
Career Start Year
1999
Number of shared co-authors
10
Phillip G Febbo
Illumina Inc.
Career Start Year
1997
Number of shared co-authors
11
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year
1993
Number of shared co-authors
37
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year
1993
Number of shared co-authors
26
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year
1990
Number of shared co-authors
5
Guido Jenster
Erasmus University Medical Center
Career Start Year
1990
Number of shared co-authors
11
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
14
Colin C Collins
University of British Columbia
Career Start Year
1988
Number of shared co-authors
28
row(s) 1 - 30 of 30
Collaborators
Amina Zoubeidi
University of British Columbia
Co-authored papers
8
Jesper Q Svejstrup
Panum Institute, University of Copenhagen
Co-authored papers
7
Jason S Carroll
Co-authored papers
7
Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Co-authored papers
6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers
5
Renea A Taylor
Peter MacCallum Cancer Centre
Co-authored papers
5
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers
5
Stephen R Plymate
University of Washington
Co-authored papers
4
Martin E Gleave
University of British Columbia
Co-authored papers
4
Ian G Mills
Queen's University Belfast
Co-authored papers
3
Richard J Rebello
University of Melbourne
Co-authored papers
3
Alastair Davies
University of British Columbia
Co-authored papers
3
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
3
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers
3
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers
3
David J Lynn
South Australian Health and Medical Research Institute
Co-authored papers
3
Mark Frydenberg
Monash University
Co-authored papers
3
Judith A Clements
Co-authored papers
2
Andries M Bergman
The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital
Co-authored papers
2
Xiaochun Li
Co-authored papers
2
Ladan Fazli
University of British Columbia
Co-authored papers
2
Ashley E Ross
Northwestern University
Co-authored papers
2
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers
2
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers
2
Kim N Chi
University of British Columbia
Co-authored papers
2
Charlie E Massie
University of Cambridge
Co-authored papers
2
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
2
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Co-authored papers
2
Gerhard A Coetzee
Van Andel Institute
Co-authored papers
2
1 - 30